Being aware that AMPs other than DCD play a role in HS etio-pathogenesis, restoring physiological levels of DCD in HS patients could be very interesting ansinced this molecule could constitute a novel target for personalised therapeutic approach. The gene discussed is ADSL; the disease is histiocytic sarcoma.